Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Adarkwah, Charles Christian
Gandjour, Afschin
Akkerman, Maren
Evers, Silvia M.
and
Araujo, Ronaldo
2011.
Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands – A Markov Model.
PLoS ONE,
Vol. 6,
Issue. 10,
p.
e26139.
Adarkwah, Charles Christian
and
Gandjour, Afschin
2011.
Cost–effectiveness of angiotensin-converting enzyme inhibitors in nondiabetic advanced renal disease.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 11,
Issue. 2,
p.
215.
Adarkwah, Charles Christian
Gandjour, Afschin
Akkerman, Maren
and
Evers, Silvia
2013.
To Treat or Not to Treat? Cost-Effectiveness of Ace Inhibitors in Non-Diabetic Advanced Renal Disease - a Dutch Perspective.
Kidney and Blood Pressure Research,
Vol. 37,
Issue. 2-3,
p.
168.
Huang, Yunyu
Zhou, Qiyun
Haaijer-Ruskamp, Flora M
and
Postma, Maarten J
2014.
Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review.
BMC Nephrology,
Vol. 15,
Issue. 1,
Gandjour, Afschin
Tschulena, Ulrich
Steppan, Sonja
and
Gatti, Emanuele
2015.
A simulation model to estimate cost-offsets for a disease-management program for chronic kidney disease.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 15,
Issue. 2,
p.
341.
Gandjour, Afschin
2015.
Avoiding research waste through cost-effectiveness analysis: the example of medication adherence-enhancing interventions.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 15,
Issue. 1,
p.
43.
Sutton, Andrew J.
Breheny, Katie
Deeks, Jon
Khunti, Kamlesh
Sharpe, Claire
Ottridge, Ryan S.
Stevens, Paul E.
Cockwell, Paul
Kalra, Philp A.
Lamb, Edmund J.
and
Hwang, Shang-Jyh
2015.
Methods Used in Economic Evaluations of Chronic Kidney Disease Testing — A Systematic Review.
PLOS ONE,
Vol. 10,
Issue. 10,
p.
e0140063.
Wu, Bin
Zhang, Suhua
Lin, Houwen
and
Mou, Shan
2018.
Prevention of renal failure in Chinese patients with newly diagnosed type 2 diabetes: A cost‐effectiveness analysis.
Journal of Diabetes Investigation,
Vol. 9,
Issue. 1,
p.
152.
Sugrue, Daniel M.
Ward, Thomas
Rai, Sukhvir
McEwan, Phil
and
van Haalen, Heleen G. M.
2019.
Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design.
PharmacoEconomics,
Vol. 37,
Issue. 12,
p.
1451.
Wang, Fangfang
and
Zhou, Bo
2020.
Investigation of angiotensin-I-converting enzyme (ACE) inhibitory tri-peptides: a combination of 3D-QSAR and molecular docking simulations.
RSC Advances,
Vol. 10,
Issue. 59,
p.
35811.
Kairys, Paul
Frese, Thomas
Voigt, Paul
Horn, Johannes
Girndt, Matthias
Mikolajczyk, Rafael
and
Shimosawa, Tatsuo
2022.
Development of the simulation-based German albuminuria screening model (S-GASM) for estimating the cost-effectiveness of albuminuria screening in Germany.
PLOS ONE,
Vol. 17,
Issue. 1,
p.
e0262227.
Lamb, Edmund J
Barratt, Jonathan
Brettell, Elizabeth A
Cockwell, Paul
Dalton, R Nei
Deeks, Jon J
Eaglestone, Gillian
Pellatt-Higgins, Tracy
Kalra, Philip A
Khunti, Kamlesh
Loud, Fiona C
Ottridge, Ryan S
Potter, Aisling
Rowe, Ceri
Scandrett, Katie
Sitch, Alice J
Stevens, Paul E
Sharpe, Claire C
Shinkins, Bethany
Smith, Alison
Sutton, Andrew J
and
Taal, Maarten W
2024.
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study.
Health Technology Assessment,
p.
1.
Rokhman, M. Rifqi
Alkaff, Firas Farisi
van Dorst, Pim W.M.
At Thobari, Jarir
Postma, Maarten J.
van der Schans, Jurjen
and
Boersma, Cornelis
2024.
Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review.
Value in Health,
Vol. 27,
Issue. 1,
p.
117.